Cargando…
Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSD) is widely recognized as a CNS demyelinating disease associated with AQP4-IgG (T cell–dependent antibody), and its trigger is still unclear. In addition, although the treatment of NMOSD currently can rely on traditional immuno...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326831/ https://www.ncbi.nlm.nih.gov/pubmed/37414573 http://dx.doi.org/10.1212/NXI.0000000000200134 |
_version_ | 1785069504895647744 |
---|---|
author | Miao, Yu Shi, Ziyan Zhang, Wei Zhu, Lin Tang, Shanshan Chen, Hongxi Wang, Xiaofei Du, Qin Li, Shuaicheng Zhang, Ying Luo, Wenqin Jin, Xin Fang, Mingyan Zhou, Hongyu |
author_facet | Miao, Yu Shi, Ziyan Zhang, Wei Zhu, Lin Tang, Shanshan Chen, Hongxi Wang, Xiaofei Du, Qin Li, Shuaicheng Zhang, Ying Luo, Wenqin Jin, Xin Fang, Mingyan Zhou, Hongyu |
author_sort | Miao, Yu |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSD) is widely recognized as a CNS demyelinating disease associated with AQP4-IgG (T cell–dependent antibody), and its trigger is still unclear. In addition, although the treatment of NMOSD currently can rely on traditional immunosuppressive and modulating agents, effective methods to predict the efficacy of these therapeutics are lacking. METHODS: In this study, high-throughput T-cell receptor (TCR) sequencing was performed on peripheral blood from 151 pretreatment patients with AQP4-IgG(+) NMOSD and 151 healthy individuals. We compared the TCR repertoire of those with NMOSD with that of healthy individuals and identified TCR clones that were significantly enriched in NMOSD. In addition, we treated 28 patients with AQP4-IgG(+) NMOSD with immunosuppressants and followed up for 6 months to compare changes in NMOSD-specific TCRs (NMOSD-TCRs) before and after treatment. Moreover, we analyzed transcriptome and single-cell B-cell receptor (BCR) data from public databases and performed T-cell activation experiments using antigenic epitopes of cytomegalovirus (CMV) to further explore the triggers of AQP4-IgG(+) NMOSD. RESULTS: Compared with healthy controls, patients with AQP4-IgG(+) NMOSD had significantly reduced diversity and shorter CDR3 length of TCRβ repertoire. Furthermore, we identified 597 NMOSD-TCRs with a high sequence similarity that have the potential to be used in the diagnosis and prognosis of NMOSD. The characterization of NMOSD-TCRs and pathology-associated clonotype annotation indicated that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection, which was further corroborated by transcriptome and single-cell BCR analysis results from public databases and T-cell activation experiments. DISCUSSION: Our findings suggest that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection. In conclusion, our study provides new clues to uncover the causative factors of AQP4-IgG(+) NMOSD and provides a theoretical foundation for treating and monitoring the disease. |
format | Online Article Text |
id | pubmed-10326831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103268312023-07-08 Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders Miao, Yu Shi, Ziyan Zhang, Wei Zhu, Lin Tang, Shanshan Chen, Hongxi Wang, Xiaofei Du, Qin Li, Shuaicheng Zhang, Ying Luo, Wenqin Jin, Xin Fang, Mingyan Zhou, Hongyu Neurol Neuroimmunol Neuroinflamm Research Article BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSD) is widely recognized as a CNS demyelinating disease associated with AQP4-IgG (T cell–dependent antibody), and its trigger is still unclear. In addition, although the treatment of NMOSD currently can rely on traditional immunosuppressive and modulating agents, effective methods to predict the efficacy of these therapeutics are lacking. METHODS: In this study, high-throughput T-cell receptor (TCR) sequencing was performed on peripheral blood from 151 pretreatment patients with AQP4-IgG(+) NMOSD and 151 healthy individuals. We compared the TCR repertoire of those with NMOSD with that of healthy individuals and identified TCR clones that were significantly enriched in NMOSD. In addition, we treated 28 patients with AQP4-IgG(+) NMOSD with immunosuppressants and followed up for 6 months to compare changes in NMOSD-specific TCRs (NMOSD-TCRs) before and after treatment. Moreover, we analyzed transcriptome and single-cell B-cell receptor (BCR) data from public databases and performed T-cell activation experiments using antigenic epitopes of cytomegalovirus (CMV) to further explore the triggers of AQP4-IgG(+) NMOSD. RESULTS: Compared with healthy controls, patients with AQP4-IgG(+) NMOSD had significantly reduced diversity and shorter CDR3 length of TCRβ repertoire. Furthermore, we identified 597 NMOSD-TCRs with a high sequence similarity that have the potential to be used in the diagnosis and prognosis of NMOSD. The characterization of NMOSD-TCRs and pathology-associated clonotype annotation indicated that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection, which was further corroborated by transcriptome and single-cell BCR analysis results from public databases and T-cell activation experiments. DISCUSSION: Our findings suggest that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection. In conclusion, our study provides new clues to uncover the causative factors of AQP4-IgG(+) NMOSD and provides a theoretical foundation for treating and monitoring the disease. Lippincott Williams & Wilkins 2023-07-06 /pmc/articles/PMC10326831/ /pubmed/37414573 http://dx.doi.org/10.1212/NXI.0000000000200134 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Research Article Miao, Yu Shi, Ziyan Zhang, Wei Zhu, Lin Tang, Shanshan Chen, Hongxi Wang, Xiaofei Du, Qin Li, Shuaicheng Zhang, Ying Luo, Wenqin Jin, Xin Fang, Mingyan Zhou, Hongyu Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders |
title | Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders |
title_full | Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders |
title_fullStr | Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders |
title_full_unstemmed | Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders |
title_short | Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders |
title_sort | immune repertoire profiling reveals its clinical application potential and triggers for neuromyelitis optica spectrum disorders |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326831/ https://www.ncbi.nlm.nih.gov/pubmed/37414573 http://dx.doi.org/10.1212/NXI.0000000000200134 |
work_keys_str_mv | AT miaoyu immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT shiziyan immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT zhangwei immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT zhulin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT tangshanshan immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT chenhongxi immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT wangxiaofei immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT duqin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT lishuaicheng immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT zhangying immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT luowenqin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT jinxin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT fangmingyan immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders AT zhouhongyu immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders |